Recruiting

DIgitAl diabeTES Treatment - the Healthy Eating, heaLthy Patients Trial

This randomized controlled trial will assess the impact of the FoodSwitch mobile app, which provides interpretive front-of-pack labelling via barcode scanning, in 900 Swedish adults with type 2 diabetes. Participants will be randomized to app + standard advice or standard advice alone. The primary outcome is change in HbA1c at 6 months; secondary outcomes include anthropometrics, quality of life, medication use, hospitalizations, and mortality.

ClinicalTrials.gov IDNCT05977218

PhaseNA

Enrollment900

SponsorLinkoeping University

Age18 Years

SexALL

I'm interested View official listing

Conditions studied

Type 2 Diabetes

About this study

Interventions

Other: FoodSwitch — Access to the 'DiabetesSwitch' filter of the FoodSwitch app when grocery shopping. When a packaged food item bar code is scanned, the FoodSwitch app will show an interpretive nutritional information score for the scanned product and recommend alternate healthier food options in the same category.

Primary outcomes

Mean HbA1c (Change from baseline at week 26)

Eligibility information

Inclusion criteria: * Age between 18 and 75 years * Self-reported type 2 diabetes with a duration of ≥2 years * Regularly grocery shopping Exclusion criteria: * No access to BankID (a digital identification system commonly used in Sweden) * Failure to complete eligibility screening and run-in periods

Study locations

Linköping University, Linköping, Sweden

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.